Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
LENZ Therapeutics, Inc. (LENZ) had Weighted-Average Shares Outstanding (Diluted) of 31.35M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.90M |
|
$-41.49M |
|
$1.08M |
|
$0.82M |
|
$46.04M |
|
$-44.13M |
|
$2.65M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-41.49M |
|
$-44.13M |
|
$-44.02M |
|
31.35M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
31.35M |
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$268.37M |
|
$1.10M |
|
$4.17M |
|
$272.54M |
|
$25.81M |
|
-- |
|
$0.24M |
|
$26.04M |
|
$246.49M |
|
$246.49M |
|
$246.49M |
|
31.35M |
|
| Cash Flow Statement Financials | |
$-33.58M |
|
$33.16M |
|
$0.01M |
|
$25.18M |
|
$24.77M |
|
$-0.41M |
|
$4.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.40% |
|
-2321.67% |
|
-2321.67% |
|
-- |
|
-2182.43% |
|
-2182.43% |
|
$-33.60M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.31 |
|
5.54 |
|
16.24 |
|
-16.83% |
|
-16.83% |
|
-15.22% |
|
-16.83% |
|
$7.86 |
|
$-1.07 |
|
$-1.07 |
|